Stay ahead with the latest developments in biotech, regulatory affairs, and healthcare innovation. Explore articles by Nirdosh Jagota.
Stay updated with the latest news, insights, and innovations from the biotech and pharmaceutical sectors.
Digital patients can reduce the need for parts of traditional clinical trials, especially early dose selection, drug interaction studies, and selected control groups, but they
Virtual patients can strengthen clinical trials by simulating biological responses, comparing study designs, and testing assumptions before real participants are enrolled. Yet virtual patient validation must show
Digital twin validation, not added model complexity, will determine whether virtual patient models can support drug development decisions. A credible digital twin must show prospectively
Biotech digital twin validation is becoming the field’s hardest problem because building a predictive model is easier than proving it remains credible across patients, products, batches,
Biomanufacturing scale-up usually fails because the process reaches larger equipment before the development team has defined how cells, materials, operating conditions, and product quality respond to
Cultivated pet food shows how biomanufacturing can reach the market through focused products with manageable volume requirements, defined regulatory routes, and clear customer value. It turns
